Retatrutide at 12 mg weekly currently produces the largest weight loss of any published Phase 3 GLP-1-class compound, exceeding tirzepatide (22.5% in SURMOUNT-1) and semaglutide (14.9% in STEP-1) at comparable timepoints
ZBP1 promotes hepatocyte pyroptosis in acute liver injury by regulating the PGAM5/ROS pathway
Important to understand: Compounded GLP-1 medications are not FDA-approved products and dont go through the same pre-market testing, consistency checks, or safety review as brand-name drugs
Utilise time-restricted eating: Limiting your food intake to an 8 or 10-hour window helps lower baseline insulin levels
Muscle volume and jawline definition continue to improve throughout the full series and beyond as collagen builds
One 10 mg retatrutide vial (lyophilized powder) One vial of bacteriostatic water (0.9% benzyl alcohol preservative) One 3 mL mixing syringe with a longer needle (21-23 gauge) Alcohol swabs (70% isopropyl) A clean, flat, well-lit work surface A vial label or marker for recording reconstitution date and concentration Optional: U-100 insulin syringes (0.5 mL or 1 mL) for drawing doses later Why bacteriostatic water specifically
